Bussiness5 months ago
Alnylam Soars After Drug Meets Goal in Heart Disease Trial
(Bloomberg) — Alnylam Pharmaceuticals Inc. shares soared after its drug succeeded in treating a progressive and deadly form of heart disease, potentially opening up a new...
